These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 4197928)

  • 21. [Effect of virazole on the antiviral activity of poly(G) X poly(C) and other polyribonucleotide interferonogens].
    Vil'ner LM; Lashkevich VA
    Antibiotiki; 1984 Jun; 29(6):450-3. PubMed ID: 6089650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro.
    Dal Pozzo F; Galligioni V; Vaccari F; Gallina L; Battilani M; Scagliarini A
    Res Vet Sci; 2010 Apr; 88(2):339-44. PubMed ID: 19781726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
    Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
    Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes.
    Balzarini J; Lee CK; Schols D; De Clercq E
    Biochem Biophys Res Commun; 1991 Jul; 178(2):563-9. PubMed ID: 1650194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of 1-beta-D-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus.
    Chung DH; Kumarapperuma SC; Sun Y; Li Q; Chu YK; Arterburn JB; Parker WB; Smith J; Spik K; Ramanathan HN; Schmaljohn CS; Jonsson CB
    Antiviral Res; 2008 Jul; 79(1):19-27. PubMed ID: 18394724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of 5'-nucleotidase from Ehrlich ascites-tumour cells by nucleoside triphosphates.
    Murray AW; Friedrichs B
    Biochem J; 1969 Jan; 111(1):83-9. PubMed ID: 5775689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel nucleoside analog, 1-beta-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro.
    McDowell M; Gonzales SR; Kumarapperuma SC; Jeselnik M; Arterburn JB; Hanley KA
    Antiviral Res; 2010 Jul; 87(1):78-80. PubMed ID: 20416341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and properties of inosine monophosphate oxidoreductase from nitrogen-fixing nodules of cowpea (Vigna unguiculata L. Walp).
    Atkins CA; Shelp BJ; Storer PJ
    Arch Biochem Biophys; 1985 Feb; 236(2):807-14. PubMed ID: 2857550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ribavirin induced differentiation of murine erythroleukemia cells.
    Kerr SJ
    Mol Cell Biochem; 1987 Oct; 77(2):187-94. PubMed ID: 3481433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and antiviral activity of 1,2,4-triazole-3-thiocarboxamide and 1,2,4-triazole-3-carboxamidine ribonucleosides.
    Witkowski JT; Robins RK; Khare GP; Sidwell RW
    J Med Chem; 1973 Aug; 16(8):935-7. PubMed ID: 4355593
    [No Abstract]   [Full Text] [Related]  

  • 31. Active-site modification of native and mutant forms of inosine 5'-monophosphate dehydrogenase from Escherichia coli K12.
    Gilbert HJ; Drabble WT
    Biochem J; 1980 Nov; 191(2):533-41. PubMed ID: 6112982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Theoretical studies of the conformational properties of ribavirin.
    Miles DL; Miles DW; Redington P; Eyring H
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4257-60. PubMed ID: 1069980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorylation of adenosine and deoxyadenosine in Ehrlich ascites carcinoma cells resistant to 6-(Methylmercapto)purine ribonucleoside.
    Lomax CA; Henderson JF
    Can J Biochem; 1972 Apr; 50(4):423-7. PubMed ID: 4537315
    [No Abstract]   [Full Text] [Related]  

  • 34. The enzymic conversion of 1,2,4-triazole-3-carboxamide to ribavirin-5'-phosphate and its relationship to the proposed mechanism of action.
    Streeter DG; Miller JP; Robins RK; Simon LN
    Ann N Y Acad Sci; 1977 Mar; 284():201-10. PubMed ID: 212973
    [No Abstract]   [Full Text] [Related]  

  • 35. Virazole (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide; a cytostatic agent.
    Müller WE; Maidhof A; Taschner H; Zahn RK
    Biochem Pharmacol; 1977 Jun; 26(11):1071-5. PubMed ID: 880258
    [No Abstract]   [Full Text] [Related]  

  • 36. A newly developed immunofluorescent assay for determining the Pichinde virus-inhibitory effects of selected nucleoside analogues.
    Burns NJ; Barnett BB; Huffman JH; Dawson MI; Sidwell RW; De Clercq E; Kende M
    Antiviral Res; 1988 Nov; 10(1-3):89-98. PubMed ID: 3069048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of a new antiviral agent "virazole" against influenza virus infections.
    Suganuma T; Ishida N
    Tohoku J Exp Med; 1973 Aug; 110(4):405-6. PubMed ID: 4764146
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on the mechanism of antiviral action of 1-(beta-D-ribofuranosyl)-1,2,4-triazole-3-carboxamide (ribavirin).
    Drabikowska AK; Dudycz L; Shugar D
    J Med Chem; 1979 Jun; 22(6):653-7. PubMed ID: 222909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profiles of purine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
    Katahira R; Ashihara H
    Planta; 2006 Dec; 225(1):115-26. PubMed ID: 16845529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
    Sokoloski JA; Sartorelli AC
    Mol Pharmacol; 1985 Dec; 28(6):567-73. PubMed ID: 2867464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.